We are looking to in-license early-stage and late-stage assets in the U.S. and China
Innovation, access to medicine and drug affordability are key factors to patient care. To improve patient care, Fosun Pharma USA is continuously actively seeking industry partnership opportunities.
Fosun Pharma USA’s partnering philosophy
Strategic alliances and partnerships form a critical foundation for our continued growth and success. We have an open, transparent and flexible approach to partnering and we seek to grow our business in the U.S. and across the globe both organically and through strategic alliances.
Fosun Pharma USA’s partnering capabilities include:
- Global reach, with a focus on the United States and China markets
- A full range of established capabilities across geographies including R&D, Regulatory Affairs, Clinical Development, Distribution, Marketing and Sales
- A proven track record in the identification and execution of a number of strategic partnerships and transaction types across various therapeutic areas and geographies
- A flexible approach to partnering and strategic alliances
- A trusted team of business development and alliance management professionals able to respond rapidly to industry trends and a variety of partnering opportunities
- A management team and corporate philosophy which are not only open to partnering, but recognize the unique value to be created and unlocked through partnerships
Fosun Pharma USA is seeking partnership opportunities for:
- The United States and/or China; as well as global opportunities
- Specialty/branded assets at any stage of development
- Generic and 505(b)(2) assets across dosage forms and therapeutic areas
- Preclinical and late clinical stage innovative opportunities
- Unique or broad-based technology platforms
Fosun Pharma USA Innovation Hub
Are you part of a university or research organization looking for an investor? Fosun Pharma USA Innovation Hub (FUSION) is a platform to invest and build early-stage portfolio companies.
